|
Volumn 66, Issue 2, 2006, Pages 285-286
|
Gentamicin treatment in McArdle disease: Failure to correct myophosphorylase deficiency
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENTAMICIN;
GLYCOGEN PHOSPHORYLASE;
PHOSPHORYLASE;
ADOLESCENT;
ADULT;
ARTICLE;
CASE REPORT;
DRUG EFFICACY;
DRUG TREATMENT FAILURE;
EXERCISE TOLERANCE;
FEMALE;
GENE MUTATION;
GLYCOGEN STORAGE DISEASE TYPE 5;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MALE;
MUSCLE BIOPSY;
NEPHROTOXICITY;
OTOTOXICITY;
PRIORITY JOURNAL;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
CELL CULTURE;
DRUG EFFECT;
ENERGY METABOLISM;
ENZYMOLOGY;
GENETICS;
METABOLISM;
MIDDLE AGED;
MUTATION;
MYOBLAST;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
OSMOLARITY;
SKELETAL MUSCLE;
ADOLESCENT;
ADULT;
CELLS, CULTURED;
ENERGY METABOLISM;
FEMALE;
GENTAMICINS;
GLYCOGEN PHOSPHORYLASE, MUSCLE FORM;
GLYCOGEN STORAGE DISEASE TYPE V;
HUMANS;
MAGNETIC RESONANCE SPECTROSCOPY;
MALE;
MIDDLE AGED;
MUSCLE, SKELETAL;
MUTATION;
MYOBLASTS;
OSMOLAR CONCENTRATION;
PHOSPHORYLASES;
|
EID: 33644889412
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000194212.31318.fc Document Type: Article |
Times cited : (34)
|
References (6)
|